Avenue Biosciences
Anton Klåvus is an accomplished data science professional with extensive experience in data analysis, machine learning, and technology management. Currently serving as Data Science Director at Avenue Biosciences since August 2024, Anton is responsible for developing machine learning tools, data processing pipelines, and managing projects that integrate AI. Prior roles include Data Scientist at Medaffcon, where Anton worked on real-world evidence studies to aid pharmaceutical companies, and Chief Technology Officer at Afekta Technologies, focusing on metabolomics data analysis. Additional experience includes a Data Scientist position at Blueprint Genetics, where Anton enhanced data accessibility, and a progression from Junior Researcher to PhD candidate at the University of Eastern Finland, specializing in nutritional metabolomics. Educational credentials include a Master of Science in Bioinformatics and a Bachelor of Science in Bioinformation Technology, both from Aalto University.
This person is not in any teams
This person is not in any offices
Avenue Biosciences
Avenue Biosciences is pioneering the future of biotechnology, with a mission to transform the development of protein biologics for healthcare advancements. Our cutting-edge, high-throughput engineering platform transforms the production of protein biologics by enabling the simultaneous optimization of critical elements. This breakthrough technology enhances production efficiency, accelerates development timelines, and tackles the challenges of producing complex proteins. Our goal is to drive significant progress in the pharmaceutical industry by providing turnkey solutions that streamline production, improve quality, and unlock new therapeutic possibilities. Backed by validated proof of concept and compelling data, Avenue Biosciences is on a journey to transform healthcare and push the boundaries of what’s possible in protein biologics. We're a team of brilliant minds, each an expert in their field, united by a shared mission to make a real impact in a novel area of biotechnology. We are a highly experienced, entrepreneurial minded team with an impressive scientific background, that lives and breathes a casual, committed, and positive culture and spirit. A closer look We revolutionize protein production with our groundbreaking high-throughput engineering platform. This innovative technology significantly enhances overall production efficiency and quality. We optimize the production of natural single-chain proteins, monoclonal antibodies, bispecific antibodies, fusion proteins, mRNA therapies, and vaccines. Additionally, our platform accelerates the drug and vaccine discovery process. Our mission is to accelerate the development of protein expression systems, covering new protein therapeutics, biosimilars, and other protein expression systems within the biotechnology industry. Our engineering platform empowers biotechnology and pharmaceutical industry customers to speed up development timelines and facilitate the production of difficult-to-express proteins.